Back
Corcept Therapeutics, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
39
CORT
Corcept Therapeutics, Inc.
Last Price:
$39.79
Seasonality Move:
12.82%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowCorcept Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 38.3% based on the past 21 years of stock performance.
-
Corcept Therapeutics, Inc. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
-
Is Corcept Therapeutics, Inc. Stock Undervalued?The current Corcept Therapeutics, Inc. [CORT] share price is $39.87. The Score for CORT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 38.3% based on the past 21 years of stock performance.
Corcept Therapeutics, Inc. Stock Rating
Sell
39
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. overpriced?
-
Corcept Therapeutics, Inc. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
Corcept Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
117.33
52-Week Low:
32.99
Prediction Charts
Market Cap:
4.2B
Price in USD:
39.87
Volume:
5.1M
Beta:
0.78
Technical Analysis
SMA50:
64.26
SMA100:
70.87
SMA200:
71.05
52-Wk Change:
-42.96%
Stock Predictions
-
Is Corcept Therapeutics, Inc. stock public?Yes, Corcept Therapeutics, Inc. is a publicly traded company.
-
What is the Corcept Therapeutics, Inc. stock quote today?The Corcept Therapeutics, Inc. stock price is 39.87 USD today.
-
How to buy Corcept Therapeutics, Inc. stock online?You can buy Corcept Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-12 | 37.44 | 37.36 | 38.11 | 37.00 |
| Jan-13 | 37.35 | 36.35 | 37.46 | 36.23 |
| Jan-14 | 36.10 | 37.04 | 37.48 | 35.71 |
| Jan-15 | 37.00 | 35.39 | 37.22 | 35.16 |
| Jan-16 | 35.39 | 34.73 | 35.86 | 34.54 |
| Jan-20 | 34.11 | 35.29 | 35.31 | 33.80 |
| Jan-21 | 35.29 | 36.31 | 37.50 | 35.00 |
| Jan-22 | 41.51 | 41.30 | 43.50 | 40.46 |
| Jan-23 | 41.77 | 43.98 | 44.84 | 41.41 |
| Jan-26 | 43.21 | 45.64 | 45.67 | 42.90 |
| Jan-27 | 45.53 | 46.22 | 46.29 | 43.52 |
| Jan-28 | 46.26 | 45.85 | 47.06 | 45.24 |
| Jan-29 | 45.74 | 44.61 | 46.09 | 44.34 |
| Jan-30 | 37.39 | 39.87 | 40.72 | 36.80 |
Corcept Therapeutics, Inc. Earnings
Corcept Therapeutics, Inc. Earnings Report: Per Share Corcept Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics, Inc. Forecast Revenue Growth
Corcept Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $2.33 per share.
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.